Differential effects of chlorinated and oxidized phospholipids in vascular tissue: Implications for neointima formation

Clinical Science

Volumn 128, Issue 9, 2015, Pages 579-592

  Greig, Fiona H ^a   Hutchison, Lisa ^a   Spickett, Corinne M ^b   Kennedy, Simon ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

Apoptosis; Chlorinated lipids; Oxidized phospholipids; Proliferation; Restenosis; Vascular smooth muscle

Indexed keywords

APOLIPOPROTEIN E; CHLORINATED PHOSPHOLIPID; LYSOPHOSPHATIDYLCHOLINE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED PHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID DERIVATIVE; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG; LOW DENSITY LIPOPROTEIN; PEROXIDASE; PHOSPHOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD VESSEL INJURY; CAROTID ARTERY LIGATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; VASCULAR TISSUE; ANIMAL; C57BL MOUSE; CAROTID ARTERY; CAROTID ARTERY INJURIES; CELL CULTURE; CELL MOTION; CELL SURVIVAL; COMPARATIVE STUDY; DEFICIENCY; DISEASE MODEL; GENETICS; HALOGENATION; INJURIES; KNOCKOUT MOUSE; LIPID DIET; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PHENOTYPE; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOLIPOPROTEINS E; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; HALOGENATION; LIPOPROTEINS, LDL; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; OXIDATION-REDUCTION; PEROXIDASE; PHENOTYPE; PHOSPHOLIPIDS; VASCULAR REMODELING;

EID: 84927171859     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20140578     Document Type: Article

References (49)

1. Goel, S.A., Guo, L.W., Liu, B. and Kent, K.C. (2012) Mechanisms of post-intervention arterial remodelling. Cardiovasc. Res. 96, 363-371
2. Jukema, J.W., Verschuren, J.J., Ahmed, T.A. and Quax, P.H. (2012) Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat. Rev. Cardiol. 9, 53-62
3. Kennedy, S., McPhaden, A.R., Wadsworth, R.M. and Wainwright, C.L. (2000) Correlation of leukocyte adhesiveness, adhesion molecule expression and leukocyte-induced contraction following balloon angioplasty. Br. J. Pharmacol. 130, 95-103
4. Coats, P., Kennedy, S., Pyne, S., Wainwright, C.L. and Wadsworth, R.A. (2008) Inhibition of non-Ras protein farnesylation reduces in-stent restenosis. Atherosclerosis 197, 515-523
5. Tennant, G.M., Wadsworth, R.M. and Kennedy, S. (2008) PAR-2 mediates increased inflammatory cell adhesion and neointima formation following vascular injury in the mouse. Atherosclerosis 198, 57-64
6. Miller, A.M., McPhaden, A.R., Wadsworth, R.M. and Wainwright, C.L. (2001) Inhibition by leukocyte depletion of neointima formation after balloon angioplasty in a rabbit model of restenosis. Cardiovasc. Res. 49, 838-850
7. Matter, C.M., Ma, L., von Lukowicz, T., Meier, P., Lohmann, C., Zhang, D., Kilic, U., Hofmann, E., Ha, S.W., Hersberger, M. et al. (2006) Increased balloon-induced inflammation, proliferation, and neointima formation in apolipoprotein E (ApoE) knockout mice. Stroke 37, 2625-2632
8. Ali, Z.A., Alp, N.J., Lupton, H., Arnold, N., Bannister, T., Hu, Y., Mussa, S., Wheatcroft, M., Greaves, D.R., Gunn, J. and Channon, K.M. (2007) Increased in-stent stenosis in ApoE knockout mice: insights from a novel mouse model of balloon angioplasty and stenting. Arterioscler. Thromb. Vasc. Biol. 27, 833-840
9. Witztum, J.L. and Steinberg, D. (1991) Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88, 1785-1792
10. Schultz, J. and Kaminker, K. (1962) Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization. Arch. Biochem. Biophys. 96, 465-467
11. Winterbourn, C.C., Vandenberg, J.J.M., Roitman, E. and Kuypers, F.A. (1992) Chlorohydrin formation from unsaturated fatty-acids reacted with hypochlorous acid. Arch. Biochem. Biophys. 296, 547-555
12. Daugherty, A., Dunn, J.L., Rateri, D.L. and Heinecke, J.W. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94, 437-444
13. Hazell, L.J., Arnold, L., Flowers, D., Waeg, G., Malle, E. and Stocker, R. (1996) Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97, 1535-1544
14. Hazell, L.J., Baernthaler, G. and Stocker, R. (2001) Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis. Free Radic. Biol. Med. 31, 1254-1262
15. Spickett, C.M. (2007) Chlorinated lipids and fatty acids: An emerging role in pathology. Pharmacol. Ther. 115, 400-409
16. Greig, F.H., Kennedy, S. and Spickett, C.M. (2012) Physiological effects of oxidized phospholipids and their cellular signaling mechanisms in inflammation. Free Radic. Biol. Med. 52, 266-280
17. Carr, A.C., Vissers, M.C., Domigan, N.M. and Winterbourn, C.C. (1997) Modification of red cell membrane lipids by hypochlorous acid and haemolysis by preformed lipid chlorohydrins. Redox Rep. 3, 263-271
18. Vissers, M.C.M., Carr, A.C. and Winterbourn, C.C. (2001) Fatty acid chlorohydrins and bromohydrins are cytotoxic to human endothelial cells. Redox Rep. 6, 49-56
19. Dever, G.J., Benson, R., Wainwright, C.L., Kennedy, S. and Spickett, C.M. (2008) Phospholipid chlorohydrin induces leukocyte adhesion to ApoE-/- mouse arteries via upregulation of P-selectin. Free Radic. Biol. Med. 44, 452-463
20. Messner, M.C., Albert, C.J., McHowat, J. and Ford, D.A. (2008) Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions. Lipids 43, 243-249
21. Franco-Pons, N., Casas, J., Fabrias, G., Gea-Sorli, S., de-Madaria, E., Gelpi, E. and Closa, D. (2013) Fat necrosis generates proinflammatory halogenated lipids during acute pancreatitis. Ann. Surg. 257, 943-951
22. Albert, C.J., Crowley, J.R., Hsu, F.F., Thukkani, A.K. and Ford, D.A. (2001) Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens - identification of 2-chlorohexadecanal. J. Biol. Chem. 276, 23733-23741
23. Thukkani, A.K., McHowat, J., Hsu, F.-F., Brennan, M.-L., Hazen, S.L. and Ford, D.A. (2003) Identification of a-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation 108, 3128-3133
24. Gargalovic, P.S., Imura, M., Zhang, B., Gharavi, N.M., Clark, M.J., Pagnon, J., Yang, W.P., He, A., Truong, A., Patel, S. et al. (2006) Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc. Natl. Acad. Sci. U.S.A. 103, 12741-12746
25. Pidkovka, N.A., Cherepanova, O.A., Yoshida, T., Alexander, M.R., Deaton, R.A., Thomas, J.A., Leitinger, N. and Owens, G.K. (2007) Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ. Res. 101, 792-801
26. Furnkranz, A., Schober, A., Bochkov, V.N., Bashtrykov, P., Kronke, G., Kadl, A., Binder, B.R., Weber, C. and Leitinger, N. (2005) Oxidized phospholipids trigger atherogenic inflammation in murine arteries. Arterioscler. Thromb. Vasc. Biol. 25, 633-638
27. Auge, N., Garcia, V., Maupas-Schwalm, F., Levade, T., Salvayre, R. and Negre-Salvayre, A. (2002) Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arterioscler. Thromb. Vasc. Biol. 22, 1990-1995
28. Fruhwirth, G.O., Moumtzi, A., Loidl, A., Ingolic, E. and Hermetter, A. (2006) The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells. Biochim. Biophys. Acta 1761, 1060-1069
29. Johnstone, S.R., Ross, J., Rizzo, M.J., Straub, A.C., Lampe, P.D., Leitinger, N. and Isakson, B.E. (2009) Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation. Am. J. Pathol. 175, 916-924
30. Cherepanova, O.A., Pidkovka, N.A., Sarmento, O.F., Yoshida, T., Gan, Q., Adiguzel, E., Bendeck, M.P., Berliner, J., Leitinger, N. and Owens, G.K. (2009) Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ. Res. 104, 609-618
31. Kumar, A. and Lindner, V. (1997) Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler. Thromb. Vasc. Biol. 17, 2238-2244
32. Spickett, C.M., Rennie, N., Winter, H., Zambonin, L., Landi, L., Jerlich, A., Schaur, R.J. and Pitt, A.R. (2001) Detection of phospholipid oxidation in oxidatively stressed cells by reversed-phase HPLC coupled with positive-ionization electroscopy MS. Biochem. J. 355, 449-457
33. Thukkani, A.K., Hsu, F.F., Crowley, J.R., Wysolmerski, R.B., Albert, C.J. and Ford, D.A. (2002) Reactive chlorinating species produced during neutrophil activation target tissue plasmalogens - production of the chemoattractant, 2-chlorohexadecanal. J. Biol. Chem. 277, 3842-3849
34. Zhu, B., Kuhel, D.G., Witte, D.P. and Hui, D.Y. (2000) Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice. Am. J. Pathol. 157, 1839-1848
35. Grassia, G., Maddaluno, M., Guglielmotti, A., Mangano, G., Biondi, G., Maffia, P. and Ialenti, A. (2009) The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice. Cardiovasc. Res. 84, 485-493
36. Yang, J., Cheng, Y., Ji, R. and Zhang, C. (2006) Novel model of inflammatory neointima formation reveals a potential role of myeloperoxidase in neointimal hyperplasia. Am. J. Physiol. Heart Circ. Physiol. 291, H3087-H3093
37. Hsieh, C.C., Yen, M.H., Liu, H.W. and Lau, Y.T. (2000) Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL. Atherosclerosis 151, 481-491
38. Rong, J.X., Berman, J.W., Taubman, M.B. and Fisher, E.A. (2002) Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 22, 1617-1623
39. Spickett, C.M., Reis, A. and Pitt, A.R. (2011) Identification of oxidized phospholipids by electrospray ionization mass spectrometry and LC-MS using a QQLIT instrument. Free Radic. Biol. Med. 51, 2133-2149
40. Katrantzis, M., Baker, M.S., Handley, C.J. and Lowther, D.A. (1991) The oxidant hypochlorite (OCl-), a product of the myeloperoxidase system, degrades articular cartilage proteoglycan aggregate. Free Radic. Biol. Med. 10, 101-109
41. Ravandi, A., Babaei, S., Leung, R., Monge, J.C., Hoppe, G., Hoff, H., Kamido, H. and Kuksis, A. (2004) Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development. Lipids 39, 97-109
42. Watson, A.D., Leitinger, N., Navab, M., Faull, K.F., Horkko, S., Witztum, J.L., Palinski, W., Schwenke, D., Salomon, R.G., Sha, W. et al. (1997) Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272, 13597-13607
43. Subbanagounder, G., Watson, A.D. and Berliner, J.A. (2000) Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities. Free Radic. Biol. Med. 28, 1751-1761
44. Dever, G., Wainwright, C.L., Kennedy, S. and Spickett, C.M. (2006) Fatty acid and phospholipid chlorohydrins cause cell stress and endothelial adhesion. Acta Biochim. Pol. 53, 761-768
45. Marsche, G., Heller, R., Fauler, G., Kovacevic, A., Nuszkowski, A., Graier, W., Sattler, W. and Malle, E. (2004) 2-Chlorohexdecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis. Arterioscler. Thromb. Vasc. Biol. 24, 2303-2306
46. Messner, M.C., Albert, C.J. and Ford, D.A. (2008) 2-Chlorohexadecanal and 2-chlorohexadecanoic acid induce COX-2 expression in human coronary artery endothelial cells. Lipids 43, 581-588
47. Loidl, A., Sevcsik, E., Riesenhuber, G., Deigner, H.P. and Hermetter, A. (2003) Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells. J. Biol. Chem. 278, 32921-32928
48. Loidl, A., Claus, R., Ingolic, E., Deigner, H.P. and Hermetter, A. (2004) Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells. Biochim. Biophys. Acta 1690, 150-158
49. Stemmer, U., Dunai, Z.A., Koller, D., Purstinger, G., Zenzmaier, E., Deigner, H.P., Aflaki, E., Kratky, D. and Hermetter, A. (2012) Toxicity of oxidized phospholipids in cultured macrophages. Lipids Health Dis. 11, 110